$3.32T
Total marketcap
$125.02B
Total volume
BTC 57.44%     ETH 12.02%
Dominance

Nxera Pharma SOLTF Stock

$5.48   11.608965%
Add to favorites
Market Cap
$500.70M
LOW - HIGH [24H]
$5.54 - $5.60
VOLUME [24H]
$1.20K
P/E Ratio
0
Earnings per share
-$0.23
Price   Prediction

Nxera Pharma Price Chart

Sorry, that's all we've gotfor now...

Nxera Pharma SOLTF Financial and Trading Overview

Nxera Pharma stock price 5.48 USD
Previous Close {summary_details__previousClose}
Open {summary_details__open}
Bid {summary_details__bid} x {summary_details__bidSize}
Ask {summary_details__ask} x {summary_details__askSize}
Day's Range 21.33 - 21.33 USD
52 Week Range 8.44 - 22.78 USD
Volume {summary_details__volume}
Avg. Volume {summary_details__averageVolume}
Market Cap {summary_details__marketCap}
Beta (5Y Monthly) {summary_details__beta}
PE Ratio (TTM) {summary_details__trailingPE}
EPS (TTM) -0.23 USD
Forward Dividend & Yield {summary_details__dividendRate} ({summary_details__dividendYield})
Ex-Dividend Date {summary_details__exDividendDate}
1y Target Est {financial_data__targetMeanPrice}

SOLTF Valuation Measures

Enterprise Value {default_key_statistics__enterpriseValue}
Trailing P/E {summary_details__trailingPE}
Forward P/E {summary_details__forwardPE}
PEG Ratio (5 yr expected) {default_key_statistics__pegRatio}
Price/Sales (ttm) {summary_details__priceToSalesTrailing12Months}
Price/Book (mrq) {default_key_statistics__priceToBook}
Enterprise Value/Revenue {default_key_statistics__enterpriseToRevenue}
Enterprise Value/EBITDA {default_key_statistics__enterpriseToEbitda}

Trading Information

Nxera Pharma Stock Price History

Beta (5Y Monthly) {default_key_statistics__beta}
52-Week Change {default_key_statistics__52WeekChange}
S&P500 52-Week Change {default_key_statistics__SandP52WeekChange}
52 Week High {summary_details__fiftyTwoWeekHigh}
52 Week Low {summary_details__fiftyTwoWeekLow}
50-Day Moving Average {summary_details__fiftyDayAverage}
200-Day Moving Average {summary_details__twoHundredDayAverage}

SOLTF Share Statistics

Avg. Volume (3 month) {summary_details__averageVolume}
Avg. Daily Volume (10-Days) {summary_details__averageDailyVolume10Day}
Shares Outstanding {default_key_statistics__sharesOutstanding}
Float {default_key_statistics__floatShares}
Short Ratio {default_key_statistics__shortRatio}
% Held by Insiders {default_key_statistics__heldPercentInsiders}
% Held by Institutions {default_key_statistics__heldPercentInstitutions}
Shares Short {default_key_statistics__sharesShort}
Short % of Float {default_key_statistics__shortPercentOfFloat}
Short % of Shares Outstanding {default_key_statistics__sharesPercentSharesOut}

Dividends & Splits

Trailing Annual Dividend Rate {summary_details__trailingAnnualDividendRate}
Trailing Annual Dividend Yield {summary_details__trailingAnnualDividendYield}
5 Year Average Dividend Yield {summary_details__fiveYearAvgDividendYield}
Payout Ratio {summary_details__payoutRatio}
Last Split Factor {default_key_statistics__lastSplitFactor}

Financial Highlights

Fiscal Year

Fiscal Year Ends {default_key_statistics__lastFiscalYearEnd}
Most Recent Quarter (mrq) {default_key_statistics__mostRecentQuarter}
Next Fiscal Year End {default_key_statistics__nextFiscalYearEnd}

Profitability

Profit Margin {financial_data__profitMargins}
Operating Margin (ttm) {financial_data__operatingMargins}
Gross Margin {financial_data__grossMargins}
EBITDA Margin {financial_data__ebitdaMargins}

Management Effectiveness

Return on Assets (ttm) {financial_data__returnOnAssets}
Return on Equity (ttm) {financial_data__returnOnEquity}

Income Statement

Revenue (ttm) {financial_data__totalRevenue}
Revenue Per Share (ttm) {financial_data__revenuePerShare}
Quarterly Revenue Growth (yoy) {financial_data__revenueGrowth}
Gross Profit (ttm) {financial_data__grossProfits}
EBITDA {financial_data__ebitda}
Net Income Avi to Common (ttm) {default_key_statistics__netIncomeToCommon}
Diluted EPS (ttm) {default_key_statistics__trailingEps}
Quarterly Earnings Growth (yoy) {default_key_statistics__earningsQuarterlyGrowth}

Balance Sheet

Total Cash (mrq) {financial_data__totalCash}
Total Cash Per Share (mrq) {financial_data__totalCashPerShare}
Total Debt (mrq) {financial_data__totalDebt}
Total Debt/Equity (mrq) {financial_data__debtToEquity}
Current Ratio (mrq) {financial_data__currentRatio}
Book Value Per Share (mrq) {default_key_statistics__bookValue}

Cash Flow Statement

Operating Cash Flow (ttm) {financial_data__operatingCashflow}
Levered Free Cash Flow (ttm) {financial_data__freeCashflow}

Profile of Nxera Pharma

Country United States
State {summary_profile__state}
City {summary_profile__city}
Address {summary_profile__address1}
ZIP {summary_profile__zip}
Phone {summary_profile__phone}
Website {summary_profile__website}
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees {summary_profile__fullTimeEmployees}

{summary_profile__longBusinessSummary}

Q&A For Nxera Pharma Stock

What is a current SOLTF stock price?

Nxera Pharma SOLTF stock price today per share is 5.48 USD.

How to purchase Nxera Pharma stock?

You can buy SOLTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Nxera Pharma?

The stock symbol or ticker of Nxera Pharma is SOLTF.

Which industry does the Nxera Pharma company belong to?

The Nxera Pharma industry is Biotechnology.

How many shares does Nxera Pharma have in circulation?

The max supply of Nxera Pharma shares is 91.37M.

What is Nxera Pharma Price to Earnings Ratio (PE Ratio)?

Nxera Pharma PE Ratio is now.

What was Nxera Pharma earnings per share over the trailing 12 months (TTM)?

Nxera Pharma EPS is -0.23 USD over the trailing 12 months.

Which sector does the Nxera Pharma company belong to?

The Nxera Pharma sector is Healthcare.

✨New! Portfolio🚀